See the DrugPatentWatch profile for Ranolazine
What is ranolazine ER (extended-release)?
Ranolazine ER is the extended-release form of ranolazine, a prescription medicine used to treat chronic (long-term) angina (chest pain) in people whose symptoms are not fully controlled by other heart medicines. It releases the drug slowly over time [1].
How does ranolazine ER work?
Ranolazine helps reduce angina by changing how heart cells handle electrical activity, which can improve the heart’s ability to deliver oxygen during stress and reduce chest pain episodes [1].
How is ranolazine ER taken?
Ranolazine ER is taken by mouth on a schedule set by the prescriber. Because it is extended-release, the tablet is not meant to be split or crushed unless the product directions say otherwise [1].
What is ranolazine ER used for (and when)?
It is used for chronic angina (stable angina) to help reduce chest pain in certain patients. It is not used as a fast-acting “rescue” medicine for sudden chest pain [1].
What side effects are people most concerned about?
Common side effects reported with ranolazine include dizziness, constipation, and nausea. Some people also experience headache [1].
Are there important drug or heart risks?
Ranolazine can interact with other medications, and it can affect heart rhythm in certain situations. Clinicians often check for interacting drugs and may monitor patients for rhythm-related concerns, especially in people who have other risk factors or who take medicines that can raise ranolazine levels [1].
How long does it take to work?
Extended-release ranolazine is designed for steady effects over time for angina prevention rather than immediate relief. Symptom control is typically assessed over days to weeks after starting or changing therapy, based on the patient’s response [1].
Sources
- https://www.drugs.com/ranolazine.html